VFA
CLVS

Valeo Financial Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Valeo Financial Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,500
Closed -$72K – 630
2021
Q2 		$72K Buy
12,500
+10,000
+400% +$58.6K ﹤0.01% 483
2021
Q1 		$18K Hold
2,500
– – ﹤0.01% 1216
2020
Q4 		$12K Hold
2,500
– – ﹤0.01% 1164
2020
Q3 		$15K Hold
2,500
– – ﹤0.01% 995
2020
Q2 		$17K Hold
2,500
– – ﹤0.01% 1124
2020
Q1 		$17K Buy
+2,500
New +$20.1K ﹤0.01% 938

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Valeo Financial Advisors's CLVS Position: Q3 2021 in Review

Valeo Financial Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2021, closing a stake of 12,500 shares — an estimated $72K sold.

Valeo Financial Advisors first reported a position in CLVS in Q1 2020 and held it in 6 quarters. The position peaked at $72K in Q2 2021. 157 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

  • Valeo Financial Advisors reported no remaining Clovis Oncology, Inc. position as of Q3 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 12,500 Clovis Oncology, Inc. shares in Q3 2021, an estimated $72K.
  • Valeo Financial Advisors first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 6 quarters.
  • Valeo Financial Advisors's Clovis Oncology, Inc. position peaked at $72K in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on Valeo Financial Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.